Downloadable Slideset


Program Content

  • EBC: Utility of Ki67 Testing
    Optimal Utilization of Ki67 Testing in HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Oncology and Pathology Healthcare Teams
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 04, 2022

    Expires: March 03, 2023

    View Activity


cover img faculity

Sara Tolaney, MD, MPH

Associate Professor of Medicine
Division of Breast Oncology
Harvard Medical School
Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner